These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 6615541)
21. Effect of coenzyme Q10 on warfarin hydroxylation in rat and human liver microsomes. Zhou Q; Zhou S; Chan E Curr Drug Metab; 2005 Apr; 6(2):67-81. PubMed ID: 15853759 [TBL] [Abstract][Full Text] [Related]
22. The isoenzyme pattern of cytochrome P450 in rat hepatocytes in primary culture, comparing different enzyme activities in microsomal incubations and in intact monolayers. Wortelboer HM; de Kruif CA; van Iersel AA; Falke HE; Noordhoek J; Blaauboer BJ Biochem Pharmacol; 1990 Dec; 40(11):2525-34. PubMed ID: 2268371 [TBL] [Abstract][Full Text] [Related]
23. Selective inactivation by chlorofluoroacetamides of the major phenobarbital-inducible form(s) of rat liver cytochrome P-450. Halpert J; Jaw JY; Balfour C; Kaminsky LS Drug Metab Dispos; 1990; 18(2):168-74. PubMed ID: 1971568 [TBL] [Abstract][Full Text] [Related]
24. Cytochrome P-450 isozyme/isozyme functional interactions and NADPH-cytochrome P-450 reductase concentrations as factors in microsomal metabolism of warfarin. Kaminsky LS; Guengerich FP Eur J Biochem; 1985 Jun; 149(3):479-89. PubMed ID: 3924614 [TBL] [Abstract][Full Text] [Related]
25. NADPH-dependent metabolism of estrone by human liver microsomes. Lee AJ; Mills LH; Kosh JW; Conney AH; Zhu BT J Pharmacol Exp Ther; 2002 Mar; 300(3):838-49. PubMed ID: 11861789 [TBL] [Abstract][Full Text] [Related]
26. Human liver microsomal metabolism of the enantiomers of warfarin and acenocoumarol: P450 isozyme diversity determines the differences in their pharmacokinetics. Hermans JJ; Thijssen HH Br J Pharmacol; 1993 Sep; 110(1):482-90. PubMed ID: 8220911 [TBL] [Abstract][Full Text] [Related]
27. Late preventive effects on dimethylnitrosamine, thioacetamide or galactosamine-induced liver necrosis of the inhibitor of proteases, phenylmethylsulfonyl fluoride. de Ferreyra EC; de Fenos OM; Castro JA Res Commun Chem Pathol Pharmacol; 1983 Dec; 42(3):505-8. PubMed ID: 6665306 [TBL] [Abstract][Full Text] [Related]
28. Studies of the mechanism of metabolism of thioacetamide s-oxide by rat liver microsomes. Dyroff MC; Neal RA Mol Pharmacol; 1983 Jan; 23(1):219-27. PubMed ID: 6408387 [No Abstract] [Full Text] [Related]
29. Effect of the hypolipidemic drug bezafibrate on the hepatic mixed function oxidase system of the rat: heterogeneity monooxygenase responses. Facino RM; Carini M Pharmacol Res Commun; 1981 Oct; 13(9):861-71. PubMed ID: 7335763 [No Abstract] [Full Text] [Related]
30. [Effect of Silymarine-N-methylglucamine salt on the microsomal content of cytochrome P-450 in the rat liver in acute thioacetamide intoxication]. Lohmann J; Schriewer H; Rauen HM Experientia; 1974 Nov; 30(11):1317-8. PubMed ID: 4435180 [No Abstract] [Full Text] [Related]
31. [Enzyme activities in the blood serum from rats with chronic liver damage. part 3: Effect of thioacetamide]. Kündiger R; Müller R; Bien E; Gohlke R Pharmazie; 1983 Apr; 38(4):257-61. PubMed ID: 6867088 [TBL] [Abstract][Full Text] [Related]
32. Characterization of CYP2C19 and CYP2C9 from human liver: respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations. Lasker JM; Wester MR; Aramsombatdee E; Raucy JL Arch Biochem Biophys; 1998 May; 353(1):16-28. PubMed ID: 9578596 [TBL] [Abstract][Full Text] [Related]
33. Genetic and developmental diversity of hepatic cytochromes P450. Warfarin and progesterone metabolism by hepatic microsomes from four inbred strains of rat. Kitareewan S; Walz FG Drug Metab Dispos; 1994; 22(4):607-15. PubMed ID: 7956737 [TBL] [Abstract][Full Text] [Related]
34. Liver injury and expression of cytochromes P450: evidence that regulation of CYP2A5 is different from that of other major xenobiotic metabolizing CYP enzymes. Camus-Randon AM; Raffalli F; Béréziat JC; McGregor D; Konstandi M; Lang MA Toxicol Appl Pharmacol; 1996 May; 138(1):140-8. PubMed ID: 8658503 [TBL] [Abstract][Full Text] [Related]
35. Association between rat serum cholinesterase and some phospholipid components of lipoproteins in thioacetamide-induced hepatic injury. Osada J; Aylagas H; Sánchez-Ramos B; Miró-Obradors MJ; Arce C; Cao G; Mendez-Marco MT; Palacios-Alaiz E Toxicology; 1990 Aug; 63(2):245-51. PubMed ID: 2399538 [TBL] [Abstract][Full Text] [Related]
36. Production and application of antibodies to rat liver cytochrome P-450. Kaminsky LS; Fasco MJ; Guengerich FP Methods Enzymol; 1981; 74 Pt C():262-72. PubMed ID: 7321884 [No Abstract] [Full Text] [Related]
37. A liver DNA synthesis promoter induced in rat plasma by injection of dimethylnitrosamine (DMNA) or thioacetamide. Díaz-Gil JJ; Sánchez G; Santamaría L; Trilla C; Esteban P; Escartín P; Gea T Br J Cancer; 1987 Jun; 55(6):599-604. PubMed ID: 3620300 [TBL] [Abstract][Full Text] [Related]
38. Cytochrome P-450 content and mixed-function oxidase activity in microsomes isolated from mouse skin. Pohl RJ; Philpot RM; Fouts JR Drug Metab Dispos; 1976; 4(5):442-50. PubMed ID: 10143 [TBL] [Abstract][Full Text] [Related]
39. Metabolic enantiomeric interactions: the inhibition of human (S)-warfarin-7-hydroxylase by (R)-warfarin. Kunze KL; Eddy AC; Gibaldi M; Trager WF Chirality; 1991; 3(1):24-9. PubMed ID: 2039681 [TBL] [Abstract][Full Text] [Related]
40. Effects of interleukin-6 on cytochrome P450-dependent mixed-function oxidases in the rat. Chen YL; Florentin I; Batt AM; Ferrari L; Giroud JP; Chauvelot-Moachon L Biochem Pharmacol; 1992 Jul; 44(1):137-48. PubMed ID: 1632828 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]